Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Choose from a selection of modern and traditional designs in single or twin packs to support type 1 diabetes research this Christmas. Shop online and get fast delivery.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This World Diabetes Day, we’re inviting you to celebrate by wearing your most joyful, whimsical and downright wonderful outfits.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Making treatments available
Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.
As new treatments become available, we want to make sure that they are delivered through the NHS to people with type 1 diabetes as quickly as possible.
To achieve this we provide evidence and patient input to the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). These are the two organisations that evaluate which medicines should be prescribed and paid for by the NHS, and provide guidelines to doctors about best treatment practices.
As well as providing input for NICE and SIGN treatment reviews ourselves, we work with industry and researchers to ensure that they are producing appropriate evidence for these two bodies.
We also make sure that patients’ views are represented by asking people with type 1 diabetes to take part in reviews, and we help to keep people with type 1 up to date about the best and latest treatment options so that they can discuss them with their healthcare team.
We are a member of the Medical Technology Group (MTG), a coalition of patient groups, research charities and medical device manufacturers working to improve access to cost-effective medical technologies for everyone who needs them.
In 2018 we merged with diabetes technology advocacy group INPUT to address some of the problems which delay adoption of new treatments and technology through the NHS. We also work closely with partners like Diabetes UK to advocate for faster access to technology.
A new sex and gender policy framework published today aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.
Our Access for All report, launched today, highlights how far we’ve come with advancements in diabetes technology, but shows that many people still face barriers when trying to access T1D technology.
New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D) has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.
We wrote to the producers of the hit BBC show after they broadcast jokes about type 1 diabetes.